Compare ResMed Inc. (RMD) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Vanguard Short Term Corporate Bond ETF — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while Vanguard Short Term Corporate Bond ETF trades at $78.58. The key difference: ResMed Inc. pays a 1.21% dividend while Vanguard Short Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| RMD | VCSH | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Fixed Income |
52-Week High | $293.73 | $80.20 |
52-Week Low | $182.82 | $78.45 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
